[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354890-105":59,"doc-detail-354890-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","zg16b-a-key-regulator-of-tumor-progression-and-immune-microenvironment-modulation-in-cancer-review","ZG16B - A key regulator of tumor progression and immune microenvironment modulation in cancer - Review","","Zymogen granule protein 16B (ZG16B) is a secretory lectin-like glycoprotein with essential roles in tumorigenesis and immune regulation. This review consolidates recent findings on ZG16B molecular features, biological functions, signaling pathway regulation, and clinical relevance. ZG16B enhances tumor cell proliferation, migration, invasion, and angiogenesis through Toll-like receptor, CXCR4, β-catenin, and focal adhesion kinase signaling. It also reshapes tumor microenvironment immunity by strengthening immunosuppressive myeloid-derived suppressor cells and M2 macrophages, while promoting dendritic cell maturation. ZG16B is upregulated in multiple cancers and correlates with poor prognosis.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/zg16b-a-key-regulator-of-tumor-progression-and-immune-microenvironment-modulation-in-cancer-review/354890/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/zg16b-a-key-regulator-of-tumor-progression-and-immune-microenvironment-modulation-in-cancer-review/354890.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is ZG16B and what does it do in cancer biology?","Question",{"text":112,"@type":113},"ZG16B is a secretory lectin-like glycoprotein. It contributes to tumorigenesis and immune regulation, including effects on tumor cell growth and immune suppression in the tumor microenvironment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which signaling pathways are reported to mediate ZG16B-driven tumor effects?",{"text":117,"@type":113},"ZG16B is described as activating Toll-like receptor, CXCR4, β-catenin, and focal adhesion kinase signaling pathways, which support proliferation, migration, invasion, and angiogenesis.",{"name":119,"@type":110,"acceptedAnswer":120},"How does ZG16B affect the tumor immune microenvironment?",{"text":121,"@type":113},"ZG16B can modulate immune responses by enhancing the immunosuppressive functions of myeloid-derived suppressor cells and M2 macrophages, and by promoting dendritic cell maturation.",{"name":123,"@type":110,"acceptedAnswer":124},"Are there therapeutic strategies or clinical trials targeting ZG16B?",{"text":125,"@type":113},"The review notes ZG16B-specific strategies such as monoclonal antibodies, RNA aptamers, and trans-splicing ribozymes with preclinical efficacy. It also mentions a clinical trial evaluating PBP1510, a humanized ZG16B antibody, for advanced pancreatic cancer.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},354890,1790210453,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","INTERNATIONAL JOURNAL OF MOLEcULAR MEdIcINE 57: 58, 2026  \nZG16B: A key regulator of tumor progression and immune microenvironment modulation in cancer (Review)  \n1* 1* 1* 1  \nXING‑MING cHEN , YU‑BO LIANG , JIN‑XIANG ZUO , ZI‑SHENG YANG , LE‑YU ZHANG2 , XIN‑YU ZHANG3 , PING WAN4 and YANG KE 1,5,6  \n1Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, 2  \nYunnan 650101, P.R. China; college of clinical Oncology, Kunming Medical University, Kunming, Yunnan 650118, P.R. China; 3School of Basic Medical Sciences, Kunming Medical University, Kunming, Yunnan 650500, P.R. China; 4Department of Gastroenterology, The First People's Hospital of Yunnan Province, Kunming, Yunnan 650032, P.R. China; 5Department of Surgical Education and Research, The Second Affiliated Hospital of Kunming Medical University, Kunming,  \n6  \nYunnan 650101, P.R. China; Yunnan Yunke Bio‑Technology Institution, Kunming, Yunnan 650201, P.R. China  \nReceived November 6, 2025; Accepted December 22, 2025  \nDOI: 10.3892/ijmm.2026.5729  \nAbstract. Zymogen granule protein 16B (ZG16B), also known as pancreatic adenocarcinoma upregulated factor, is a secretory lectin‑like glycoprotein that serves a crucial role in tumorigen‑ esis and immune regulation. The present review summarizes the latest research progress on the molecular characteristics, biological functions, signaling pathway regulation and clinical importance of ZG16B. Structurally, ZG16B contains an N‑terminal hydrophobic signal peptide, a jacalin‑related lectin domain and a c‑terminal extension . Functionally, ZG16B promotes tumor cell proliferation, migration, invasion and angiogenesis, and increases vascular permeability by activating the Toll‑like receptor, c‑X‑c chemokine receptor type 4, β‑catenin and focal adhesion kinase signaling path‑ ways. In the tumor microenvironment, ZG16B can modulate immune responses, enhance the immunosuppressive functions of myeloid‑derived suppressor cells and M2 macrophages, and also promote the maturation of dendritic cells. clinically, ZG16B expression is upregulated in pancreatic cancer, ovarian cancer, colorectal cancer, gastric cancer and oral cancer, and  \nCorrespondence to: Professor Yang Ke, Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, 374 Kunrui Road, Wuhua, Kunming, Yunnan 650101, P.R. China  \nE‑[mail: keyang1218@126.com](mail: keyang1218@126.com)  \nProfessor Ping Wan, Department of Gastroenterology, The First People's Hospital of Yunnan Province, 157 Jinbi Road, Xishan, Kunming, Yunnan 650032, P.R. China  \nE‑[mail: kmwp_66@126.com](mail: kmwp_66@126.com)  \n*contributed equally  \nKey words: zymogen granule protein 16B, biological functions, cancer, signaling pathways  \nits upregulation is associated with a worse prognosis in these malignancies . Several ZG16B‑specific therapeutic strate‑ gies, including monoclonal antibodies, RNA aptamers and trans‑splicing ribozymes, have shown preclinical efficacy against malignant tumors . Furthermore, a clinical trial is currently testing the efficacy and safety of PBP1510, a human‑ ized ZG16B antibody, for the treatment of advanced pancreatic cancer. In conclusion, ZG16B may be considered a novel target for cancer diagnosis, prognosis and therapy.  \nContents  \n1. Introduction  \n2. Structural characteristics of ZG16B  \n3. Paralogous homolog of ZG16B  \n4. Biological functions of ZG16B  \n5. Regulation of signaling pathways by ZG16B  \n6. Relevance of ZG16B to tumors and its translational potential  \n7. Future research directions for ZG16B  \n8. conclusion  \n1. Introduction  \nThe development and progression of cancer is a complex, multi‑step process driven by factors such as the aberrant expression of multiple genes, disruption of key signaling pathways and remodeling of the tumor microenvironment (TME) (1‑7) . A deeper understanding of the mechanisms underlying the key drivers of cancer is crucial for revealing the malignant n","cbCaioudQxlLdFEY","https://ap.wps.com/l/cbCaioudQxlLdFEY","pdf",3224223,13,"English","# Contents\n## 1. Introduction\n## 2. Structural characteristics of ZG16B\n## 3. Paralogous homolog of ZG16B\n## 4. Biological functions of ZG16B\n## 5. Regulation of signaling pathways by ZG16B\n## 6. Relevance of ZG16B to tumors and its translational potential\n## 7. Future research directions for ZG16B\n## 8. conclusion","[{\"question\":\"What is ZG16B and what does it do in cancer biology?\",\"answer\":\"ZG16B is a secretory lectin-like glycoprotein. It contributes to tumorigenesis and immune regulation, including effects on tumor cell growth and immune suppression in the tumor microenvironment.\"},{\"question\":\"Which signaling pathways are reported to mediate ZG16B-driven tumor effects?\",\"answer\":\"ZG16B is described as activating Toll-like receptor, CXCR4, β-catenin, and focal adhesion kinase signaling pathways, which support proliferation, migration, invasion, and angiogenesis.\"},{\"question\":\"How does ZG16B affect the tumor immune microenvironment?\",\"answer\":\"ZG16B can modulate immune responses by enhancing the immunosuppressive functions of myeloid-derived suppressor cells and M2 macrophages, and by promoting dendritic cell maturation.\"},{\"question\":\"Are there therapeutic strategies or clinical trials targeting ZG16B?\",\"answer\":\"The review notes ZG16B-specific strategies such as monoclonal antibodies, RNA aptamers, and trans-splicing ribozymes with preclinical efficacy. It also mentions a clinical trial evaluating PBP1510, a humanized ZG16B antibody, for advanced pancreatic cancer.\"}]","ZG16B - A key regulator of tumor progression and immune microenvironment modulation in cancer - Review | PDF",1790114646,33,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d1ce4d1e023db702225a87a12f86e56e.webp",983,1357,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e6c13dbc2fa0cdfce35af97f644adf6e.webp",982,1356,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/43ca49ba168d11ce8e25d20fa7f32f76.webp",981,1354,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/815e10994fde239ea51c1d68f6b236f2.webp",980,1353]